BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31917288)

  • 1. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
    Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B
    Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway.
    Liu L; Wang Y; Yan R; Li S; Shi M; Xiao Y; Guo B
    PLoS One; 2016; 11(3):e0151986. PubMed ID: 27010330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
    Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
    J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.
    Jin Z; Gu C; Tian F; Jia Z; Yang J
    Cell Tissue Res; 2017 Sep; 369(3):603-610. PubMed ID: 28646304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein.
    Wang Y; Mao Y; Zhang X; Liu H; Peng W; Liang L; Shi M; Xiao Y; Zhang Y; Zhang F; Yan R; Guo B
    Life Sci; 2019 Jul; 228():1-10. PubMed ID: 31028803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN.
    Xu H; Sun F; Li X; Sun L
    Hum Cell; 2018 Jan; 31(1):22-32. PubMed ID: 28707079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SnoN upregulation ameliorates renal fibrosis in diabetic nephropathy.
    Liu L; Shi M; Wang Y; Zhang C; Su B; Xiao Y; Guo B
    PLoS One; 2017; 12(3):e0174471. PubMed ID: 28350874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
    Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
    Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.
    Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH
    BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
    Ai K; Zhu X; Kang Y; Li H; Zhang L
    Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
    Yang F; Chung AC; Huang XR; Lan HY
    Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP-7 enhances SnoN mRNA expression in renal tubular epithelial cells under high-glucose conditions.
    Wang Y; Xiao Y; Li S; Shi L; Liu L; Zhang Y; Shi M; Guo B
    Mol Med Rep; 2017 Sep; 16(3):3308-3314. PubMed ID: 28765970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation.
    Poncelet AC; Schnaper HW; Tan R; Liu Y; Runyan CE
    J Biol Chem; 2007 May; 282(21):15534-40. PubMed ID: 17400544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulatory effect of berberine on unbalanced expressions of renal tissue TGF-beta1/SnoN and smad signaling pathway in rats with early diabetic nephropathy].
    Liu S; Yu N; Zhang XL; Chen XQ; Tang LQ
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3604-10. PubMed ID: 23477149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.
    Hoi S; Tsuchiya H; Itaba N; Suzuki K; Oka H; Morimoto M; Takata T; Isomoto H; Shiota G
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):940-946. PubMed ID: 32012313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of smurf2 in regulating the expression of SnoN in diabetic nephropathy.
    Xu Z; Diao Z; Liu R; Liu W
    Mol Med Rep; 2017 May; 15(5):2560-2566. PubMed ID: 28447757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood glucose control contributes to protein stability of Ski-related novel protein N in a rat model of diabetes.
    Liang L; Li S; Liu H; Mao Y; Liu L; Zhang X; Peng W; Xiao Y; Zhang F; Shi M; Wang Y; Guo B
    Exp Ther Med; 2021 Nov; 22(5):1341. PubMed ID: 34630695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.